ITMI20090967A1 - COMPOSITION FOR A NATURAL FOOD SUPPLEMENT, PARTICULARLY TO ENCOURAGE THE PHYSIOLOGICAL FUNCTIONALITY OF THE LIVER. - Google Patents
COMPOSITION FOR A NATURAL FOOD SUPPLEMENT, PARTICULARLY TO ENCOURAGE THE PHYSIOLOGICAL FUNCTIONALITY OF THE LIVER. Download PDFInfo
- Publication number
- ITMI20090967A1 ITMI20090967A1 IT000967A ITMI20090967A ITMI20090967A1 IT MI20090967 A1 ITMI20090967 A1 IT MI20090967A1 IT 000967 A IT000967 A IT 000967A IT MI20090967 A ITMI20090967 A IT MI20090967A IT MI20090967 A1 ITMI20090967 A1 IT MI20090967A1
- Authority
- IT
- Italy
- Prior art keywords
- composition
- tit
- vitamin
- liver
- fillanto
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 14
- 210000004185 liver Anatomy 0.000 title claims description 8
- 235000015872 dietary supplement Nutrition 0.000 title claims description 4
- 235000019106 Cynara scolymus Nutrition 0.000 claims description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims description 5
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims description 5
- 244000019459 Cynara cardunculus Species 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 5
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 claims description 5
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims description 5
- 235000016520 artichoke thistle Nutrition 0.000 claims description 5
- 229940074393 chlorogenic acid Drugs 0.000 claims description 5
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims description 5
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims description 5
- 235000001368 chlorogenic acid Nutrition 0.000 claims description 5
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims description 5
- 229960004245 silymarin Drugs 0.000 claims description 5
- 235000017700 silymarin Nutrition 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000010841 Silybum marianum Nutrition 0.000 claims description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 3
- 240000001949 Taraxacum officinale Species 0.000 claims description 3
- 239000013589 supplement Substances 0.000 claims description 3
- 235000019160 vitamin B3 Nutrition 0.000 claims description 3
- 239000011708 vitamin B3 Substances 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 2
- 244000309023 Cynara scolymus Species 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- 244000174716 Phaseolus caracalla Species 0.000 claims description 2
- 241000320380 Silybum Species 0.000 claims description 2
- 244000272459 Silybum marianum Species 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 229960004998 acesulfame potassium Drugs 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 2
- 239000000619 acesulfame-K Substances 0.000 claims description 2
- 239000002535 acidifier Substances 0.000 claims description 2
- 229940095602 acidifiers Drugs 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 229920001864 tannin Polymers 0.000 claims description 2
- 239000001648 tannin Substances 0.000 claims description 2
- 235000018553 tannin Nutrition 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 244000182264 Lucuma nervosa Species 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims 1
- 239000011885 synergistic combination Substances 0.000 claims 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 239000011726 vitamin B6 Substances 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 244000158996 Hedysarum boreale Species 0.000 description 1
- 244000038594 Phyllanthus urinaria Species 0.000 description 1
- 241000245665 Taraxacum Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940067866 dandelion extract Drugs 0.000 description 1
- 235000020691 dandelion extract Nutrition 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940096421 milk thistle extract Drugs 0.000 description 1
- 235000020727 milk thistle extract Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001845 taraxacum officinale leaf extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A23L1/3002—
-
- A23L1/308—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Description
"COMPOSIZIONE PER UN INTEGRATORE NATURALE ALI-MENTARE, PARTICOLARMENTE PER FAVORIRE LA FISIO-LOGICA FUNZIONALITÀ DEL FEGATO" "COMPOSITION FOR A NATURAL ALI-MENTARY SUPPLEMENT, PARTICULARLY TO FAVOR THE PHYSIO-LOGIC FUNCTIONALITY OF THE LIVER"
D E S C R I Z I O N E DESCRIPTION
Il presente trovato ha come oggetto una composizione per un integratore naturale alimentare, particolarmente per favorire la fisiologica funzionalità del fegato. The present invention relates to a composition for a natural food supplement, particularly for promoting the physiological functionality of the liver.
Compito del presente trovato à ̈ quello di realizzare una composizione in grado di svolgere un’importante azione epatoprotettrice. The aim of the present invention is to provide a composition capable of carrying out an important hepatoprotective action.
Nell’ambito di questo compito, uno scopo del trovato à ̈ quello di realizzare una composizione che favorisca i processi di rigenerazione degli epatociti. Within the scope of this aim, an object of the invention is to provide a composition which favors the regeneration processes of hepatocytes.
Un ulteriore scopo del presente trovato à ̈ quello di realizzare una composizione in grado di favorire i processi di detossificazione del fegato, e che aiuti ad inibire la perossidazione lipidica. A further object of the present invention is to provide a composition capable of favoring the detoxification processes of the liver, and which helps to inhibit lipid peroxidation.
Questo ed altri scopi, che meglio appariranno evidenziati in seguito, sono raggiunti da una composizione per un integratore naturale alimentare, particolarmente per favorire la fisiologica funzionalità del fegato, caratterizzata dal fatto di comprendere, in combinazione, le seguenti sostanze: Silimarina, Inulina, Acido Clorogenico e Fillanto Amaro. This and other purposes, which will be better highlighted later, are achieved by a composition for a natural food supplement, particularly to promote the physiological functionality of the liver, characterized by the fact of including, in combination, the following substances: Silymarin, Inulin, Acid Chlorogenic and Fillanto Amaro.
La Silimarina, che à ̈ la componente attiva dell’estratto di Cardo Mariano, svolge un’azione epatoprotettiva ed accelera il processo di rigenerazione del fegato, in quanto aumenta l’attività metabolica delle cellule epatiche. Silymarin, which is the active component of Milk Thistle extract, performs a hepatoprotective action and accelerates the regeneration process of the liver, as it increases the metabolic activity of the liver cells.
L’Inulina à ̈ la componente attiva dell’estratto di Tarassaco, e favorisce il riequilibrio della flora intestinale potenziandone l’attività . Inulin is the active component of Dandelion extract, and promotes the rebalancing of the intestinal flora by enhancing its activity.
L’Acido Clorogenico, che à ̈ la componente attiva del carciofo, incrementa la funzionalità epatica e biliare. Chlorogenic acid, which is the active component of the artichoke, increases liver and biliary function.
L’Acido Clorogenico favorisce inoltre il metabolismo lipidico aumentando l’escrezione di colesterolo, e svolge un’azione antiossidante. Chlorogenic acid also promotes lipid metabolism by increasing the excretion of cholesterol, and has an antioxidant action.
Una composizione preferita secondo l'invenzione comprende i seguenti componenti: A preferred composition according to the invention comprises the following components:
- fruttosio; - fructose;
- acido tartarico; - tartaric acid;
- sodio bicarbonato; - sodium bicarbonate;
- L-taurina; - L-taurine;
- acidificanti: acido citrico, acido malico; - acidifiers: citric acid, malic acid;
- fillanto e.s. fiori e foglie tit. 15% tannini (Phyllantus niruri) (40 mg); - fillanto e.s. flowers and leaves tit. 15% tannins (Phyllantus niruri) (40 mg);
- carciofo e.s. foglia tit. 2,5% acido clorogenico (Cynara scolymus L.) (40 mg); - artichoke d.e. leaf tit. 2.5% chlorogenic acid (Cynara scolymus L.) (40 mg);
- tarassaco e.s. e.s. radice tit. 2,0% Inulina (Taraxacuni officinale weber) (40 mg); - dandelion dry extract e.s. root tit. 2.0% Inulin (Taraxacuni officinale weber) (40 mg);
- antiagglomerante: biossido di silicio; - anti-caking agent: silicon dioxide;
- cardo mariano e.s. frutti tit. 2,0% Silimarina (Silybum marianum gaertner) (25 mg); - milk thistle dry extract fruit tit. 2.0% Silymarin (Silybum marianum gaertner) (25 mg);
- edulcorante: acesulfame potassico; - sweetener: acesulfame potassium;
- aroma; - aroma;
- vitamina PP; - vitamin PP;
- vitamina B6 cloridrato. - vitamin B6 hydrochloride.
La composizione à ̈ vantaggiosamente utilizzata per realizzare un integratore in polvere confezionato in bustine. The composition is advantageously used to make a powder supplement packaged in sachets.
L'esempio realizzativo della composizione, descritto sopra, presenta i seguenti valori nutrizionali, riferiti al contenuto di una bustina, di 100 g di prodotto e di % RDA (Recommended Daily Allowance): The example of the composition, described above, has the following nutritional values, referred to the content of a sachet, of 100 g of product and% RDA (Recommended Daily Allowance):
ANALISI MEDIA Per 1 bustina Per 100 g % RDA per Bst VitaminaPP mg 9,0 180,0 50 VitarninaB6 mg 1,0 20,0 50 Fillanto mg 40,0 800,0 AVERAGE ANALYSIS For 1 sachet For 100 g% RDA for Bst VitaminPP mg 9.0 180.0 50 VitarninaB6 mg 1.0 20.0 50 Phyllant mg 40.0 800.0
Carciofo mg 40,0 800,0 Artichoke mg 40.0 800.0
Tarassaco mg 40,0 800,0 Dandelion mg 40.0 800.0
Cardomariano mg 25,0 500,0 Cardomarian 25.0 mg 500.0
Tali percentuali possono variare del ± 30%. These percentages may vary by ± 30%.
Si à ̈ in pratica constatato che il trovato raggiunge il compito e gli scopi prefissati. In practice it has been found that the invention achieves the intended aim and objects.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A000967A IT1394710B1 (en) | 2009-06-03 | 2009-06-03 | COMPOSITION FOR A NATURAL FOOD SUPPLEMENT, PARTICULARLY TO ENCOURAGE THE PHYSIOLOGICAL FUNCTIONALITY OF THE LIVER. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A000967A IT1394710B1 (en) | 2009-06-03 | 2009-06-03 | COMPOSITION FOR A NATURAL FOOD SUPPLEMENT, PARTICULARLY TO ENCOURAGE THE PHYSIOLOGICAL FUNCTIONALITY OF THE LIVER. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20090967A1 true ITMI20090967A1 (en) | 2010-12-04 |
IT1394710B1 IT1394710B1 (en) | 2012-07-13 |
Family
ID=41506480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2009A000967A IT1394710B1 (en) | 2009-06-03 | 2009-06-03 | COMPOSITION FOR A NATURAL FOOD SUPPLEMENT, PARTICULARLY TO ENCOURAGE THE PHYSIOLOGICAL FUNCTIONALITY OF THE LIVER. |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1394710B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001013930A1 (en) * | 1999-08-26 | 2001-03-01 | Jean Julia | Dietetic use of cynara cardunculus and silybum marianum oils |
US20030044512A1 (en) * | 2001-08-31 | 2003-03-06 | Watson Brenda F. | Liver function improvement formulation |
KR20040052930A (en) * | 2004-05-18 | 2004-06-23 | 약초나라(주) | Compounds for relief of alcoholic hangover and drug containing the compounds |
US20050238654A1 (en) * | 2004-04-26 | 2005-10-27 | Yoshinori Takeda | Compositions and methods for weight loss |
US20070065456A1 (en) * | 2005-09-20 | 2007-03-22 | Woods Cindy J | Nutritional supplements |
-
2009
- 2009-06-03 IT ITMI2009A000967A patent/IT1394710B1/en active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001013930A1 (en) * | 1999-08-26 | 2001-03-01 | Jean Julia | Dietetic use of cynara cardunculus and silybum marianum oils |
US20030044512A1 (en) * | 2001-08-31 | 2003-03-06 | Watson Brenda F. | Liver function improvement formulation |
US20050238654A1 (en) * | 2004-04-26 | 2005-10-27 | Yoshinori Takeda | Compositions and methods for weight loss |
KR20040052930A (en) * | 2004-05-18 | 2004-06-23 | 약초나라(주) | Compounds for relief of alcoholic hangover and drug containing the compounds |
US20070065456A1 (en) * | 2005-09-20 | 2007-03-22 | Woods Cindy J | Nutritional supplements |
Non-Patent Citations (4)
Title |
---|
ANONYMOUS: "Ayrveda Neem Rasayana #5", 27 March 2008 (2008-03-27), pages 1 - 3, XP002563637, Retrieved from the Internet <URL:http://web.archive.org/web/20080327030050/http://www.ayurveda-herbs.com/5.htm> [retrieved on 20100116] * |
BAGALKOTKAR, G.;SAGINEEDU, S.R.; SAAD, M.S.; STANSLAS, J.: "Phytochemicals from Phyllanthus niruri Linn and their pharmacological properties: a review", J PHARM PHARMACOL, vol. 58, no. 12, 2006, pages 1559 - 1570, XP008117324 * |
CLIFFORD, M. N.: "Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden.", JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, vol. 79, 1999, pages 362 - 372, XP002563618 * |
SALLER, R.; BRIGNOLI, R.; MELZER, J.; MEIER, R.: "An updated systematic review with meta-analysis for the clinical evidence of silymarin.", FORSCH KOMPLEMENTMED., vol. 15, no. 1, 2008, pages 9 - 20, XP008117326 * |
Also Published As
Publication number | Publication date |
---|---|
IT1394710B1 (en) | 2012-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015343046B2 (en) | Methods and compositions for attenuating allergenicity in protein products | |
WO2009147158A3 (en) | Compositions of fat-soluble active ingredients containing gum ghatti | |
US20150352020A1 (en) | Compositions and methods for producing stable negative oxidation reduction potential in consumable materials | |
JPWO2014175180A1 (en) | Composition containing fructooligosaccharide and quercetin glycoside | |
RU2604008C1 (en) | Jelly marmalade production method | |
US20110124577A1 (en) | Preparation for oral administration comprises quercetin glycoside and a water-based solvent extract of cartilage containing chondroitin sulfate | |
KR101811122B1 (en) | A preparation method of jelly and beverage compositions containing Aronia extract reduced tannin and L-arginine | |
JP2011103780A (en) | Composition containing green tea-derived catechin | |
CN102090550A (en) | Jujube paste-chestnut mash | |
ITMI20090967A1 (en) | COMPOSITION FOR A NATURAL FOOD SUPPLEMENT, PARTICULARLY TO ENCOURAGE THE PHYSIOLOGICAL FUNCTIONALITY OF THE LIVER. | |
JP2017136095A (en) | Liquid food composition | |
KR101376198B1 (en) | An antioxidant and antidiabetic health functional food composition and a functional beverage composition comprising Laminaria japonica A. | |
KR20190071364A (en) | A composition for ant oxidation effect comprising Theobroma cacao L. extract | |
RU2546906C1 (en) | Enriched vitaminised dragee | |
JP7016510B2 (en) | Blood cholesterol elevation inhibitory composition | |
KR20120138392A (en) | A composition having effects of preventing alcoholic liver damage and alcoholic fat liver and of ameliorating hangover | |
KR101170351B1 (en) | Method for producing propolis extract with enhanced antioxidative activity | |
EP2510812B1 (en) | Biologically active food additive | |
RU2358562C1 (en) | Vegetable concentrate for "kazan-bionan-3" functional drink | |
GB2537444A (en) | A Chocolate composition | |
Mäkinen | The Latest on Sugar Substitutes of the Alditol Type with Special Consideration of Erythritol and Xylitol―Rectifications and Recommendations | |
JP7271017B2 (en) | Composition for suppressing elevation of blood cholesterol | |
JP2011111421A (en) | Composition having prophylactic or ameliorative effect on dropsy | |
JP2021113230A (en) | Oral composition for oral care | |
CN108402363A (en) | A kind of pick-me-up |